# John Oates

> John Oates is a startup investor at Recombination Therapeutics (Philadelphia). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Recombination Therapeutics](https://shizune.co/investors/profile/recombination-therapeutics)
- Location: Philadelphia, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jooates
- Facebook: https://www.facebook.com/john.oates.359

John Oates is a startup investor at Recombination Therapeutics in Philadelphia. John Oates is the Co-Founder and CEO of Recombination Therapeutics. He previously worked at United BioSource Corporation as a General Manager of Biotechnology Solutions. John Oates attended Alfred Lerner College of Business & Economics at the University of Delaware.

## About Recombination Therapeutics

VC Fund



1 contacts available at Recombination Therapeutics.

| Name | Title | Profile |
| --- | --- | --- |
| John Oates | Co-Founder and CEO | https://shizune.co/investors/profile/john-oates-a1d3 |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co